Reprixys Pharmaceutical Corporation
1 clinical trials · Sponsor
◉ Watch Reprixys Pharmaceutical Corporation
| Record | Firm | Date |
|---|---|---|
| Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises (NCT01895361) | Reprixys Pharmaceutical Corporation | 2013-07-01 |
Track Reprixys Pharmaceutical Corporation automatically
Every clearance here is in the API, with alerts when new ones post.